Ameliorative effects of resveratrol on liver injury in streptozotocin-induced diabetic rats

Journal of Biochemical and Molecular Toxicology

Volumn 26, Issue 10, 2012, Pages 384-392

  Hamadi, Nasereddine ^a   Mansour, Ahmed ^b   Hassan, Memy H ^b,c   Khalifi Touhami, Fatima ^a   Badary, Osama ^d  

^a Universite Mentouri Constantine   (Algeria)

^b Al Azhar University   (Egypt)

^c TAIBAH UNIVERSITY   (Saudi Arabia)

^d Ain Shams University   (Egypt)

Author keywords

Diabetes Mellitus; Oxidative Stress; Resveratrol; Streptozotocin

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CATALASE; GLUCOSE; GLUTATHIONE; GLUTATHIONE TRANSFERASE; MALONALDEHYDE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); RESVERATROL; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CHEMICAL ANALYSIS; CONTROLLED STUDY; GLUCOSE BLOOD LEVEL; HISTOPATHOLOGY; LIPID BLOOD LEVEL; LIVER; LIVER INJURY; LIVER PROTECTION; LIVER WEIGHT; MALE; NONHUMAN; OXIDATIVE STRESS; RAT; STAINING; STREPTOZOCIN DIABETES; SURVIVAL;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; LIPID PEROXIDATION; LIPIDS; LIVER; LIVER DISEASES; MALE; MALONDIALDEHYDE; ORGAN SIZE; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY; STILBENES; STREPTOZOCIN;

RATTUS;

EID: 84867748674     PISSN: 10956670     EISSN: 10990461     Source Type: Journal    
DOI: 10.1002/jbt.21432     Document Type: Article

References (54)

1. Akbarzadeh A, Norouzian D, Mehrabi MR, Jamshidi Sh, Farhangi A, Allah Verdi A, Mofidian SMA, Lame Rad B. Induction of diabetes by streptozotocin in rats. Indian J Clin Biochem 2007;22(2):60-64.
2. Bell DS, Allbright E. The multifaceted associations of hepatobiliary disease and diabetes. Endocr Pract 2007;13:300-312.
3. Chatila R, West AB. Hepatomegaly and abnormal liver tests due to glycogenosis in adults with diabetes. Medicine 1996;75:327-333.
4. Harrison SA, Brunt EM, Goodman ZD, Di Bisceglie AM. Diabetic hepatosclerosis: diabetic microangiopathy of the liver. Arch Pathol Lab Med 2006;130:27-32.
5. Saxena AK, Srivastava P, Kale RK, Baquer NZ. Impaired antioxidant status in diabetic rat liver. Effect of vanadate. Biochem Pharmacol 1993;45:539-542.
6. Marangiello R, Giorgetti R. A case of glycogenosis in a patient with insulin dependent diabetes. Minerva Pediatr 1996;48:279-281.
7. West IC. Radicals and oxidative stress in diabetes. Diabetic Med 2000;17:171-180.
8. Kiritoshi S, Nishikawa T, Sonoda K, Kukidome D, Senokuchi T, Matsuo T, Matsumura T, Tokunaga H, Brownlee M, Araki E. Reactive oxygen species from mitochondria induce cyclooxygenase-2 gene expression in human mesangial cells: potential role in diabetic nephropathy. Diabetes 2003;52:2570-2577.
9. Ohkuwa T, Sato Y, Naoi M. Hydroxyl radical formation in diabetic rats induced by streptozotocin. Life Sci 1995;56:1789-1798.
10. Nishikawa T, Edelstein D, Du XL, Yamagishi S, Matsumura T, Kaneda Y, Yorek MA, Beebe D, Oates PJ, Hammes HP, Giardino I, Brownlee M. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 2000;404:787-790.
11. Park KS, Kim JH, Kim MS, Kim JM, Kim SK, Choi JY, Chung MH, Han B, Kim SY, Lee HK. Effects of insulin and antioxidant on plasma 8-hydroxyguanine and tissue 8-hydroxydeoxyguanosine in streptozotocin-induced diabetic rats. Diabetes 2001;50:2837-2841.
12. Mahesh T, Menom VP. Quercetin alleviates oxidative stress in streptozotocin-induced diabetic rats. Phytother Res 2004;18:123-127.
13. Thirunavukkarasu M, Penumathsa SV, Koneru S, Juhasz B, Zhan L, Otani H, Bagchi D, Das DK, Maulik N. Resveratrol alleviates cardiac dysfunction in streptozotocin-induced diabetes: role of nitric oxide, thioredoxin, and heme oxygenase. Free Radic Biol Med 2007;43:720-729.
14. Yilmaz HR, Uz E, Yucel N, Altuntas I, Ozcelik N. Protective effect of caffeic acid phenethyl ester (CAPE) on lipid peroxidation and antioxidant enzymes in diabetic rat liver. J Biochem Mol Toxicol 2004;18:234-238.
15. Zhou JY, Zhou SW, Zhang KB, Tang JL, Guang LS, Ying Y, Xu Y, Zhang L, Li DD. Chronic effects of berberine on blood, liver glucolipid metabolism and liver PPARS expression in diabetic hyperlipidemic rats. Biol Pharm Bull 2008;31(6):1169-1176.
16. Signorelli P, Ghidoni R. Resveratrol as an anticancer nutrient: molecular basis, open questions and promises. J Nutr Biochem 2005;16:449-466.
17. Baur JA, Sinclair DA. Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov 2006;5:493-506.
18. Das DK, Maulik N. Resveratrol in cardioprotection: a therapeutic promise of alternative medicine. Mol Interv 2006;6:36-47.
19. Donnelly LE, Newton R, Kennedy GE, Fenwich PS, Leung RH, Ito K, Russell RE, Barnes PJ. Anti-inflammatory effects of resveratrol in lung epithelial cells: molecular mechanisms. Am J Physiol Lung Cell Mol Physiol 2004;287:L774-L783.
20. Aggarwal BB, Bhardwaj A, Aggarwal RS, Seeram NP, Shishodia S, Takada Y. Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies. Anticancer Res 2004;24(5A):2783-2840.
21. Harikumar KB, Aggarwal BB. Resveratrol: a multitargeted agent for age-associated chronic diseases. Cell Cycle 2008;7(8):1020-1035.
22. Raval AP, Lin HW, Dave KR, Defazio RA, Della Morte D, Kim EJ, Perez-Pinson MA. Resveratrol and ischemic preconditioning in the brain. Curr Med Chem. 2008;15(15):1545-1551.
23. Vidavalur R, Otani H, Singal PK, Maulik N. Significance of wine and resveratrol in cardiovascular disease: French paradox revisited. Exp Clin Cardiol 2006;11(3):217-225.
24. Rakieten N, Rakieten ML, Nadkarni MR. Studies on the diabetogenic action of streptozotocin (NSC-37917). Cancer Chemother Rep 1963;29:91-98.
25. Lazarus SS, Shapiro SH. Streptozotocin-induced diabetes and islet cell alterations in rabbits. Diabetes 1972;21(3):129-137.
26. Pitkin RM, Reynolds WA. Diabetogenic effects of streptozotocin in rhesus monkeys. Diabetes 1970; 19(2):85-90.
27. Losert W, Rilke A, Loge O, Richter KD. Comparative biochemical study on the diabetogenic effect of streptozotocin in mice, rats, Chinese hamsters and guinea pigs. Arzneimittelforschung 1971;21(11):1643-1653.
28. Ha H, Kim C, Son Y, Chung MH, Kim KH. DNA damage in the kidneys of diabetic rats exhibiting microalbuminuria. Free Radic Biol Med 1994;16:271-274.
29. Silan C. The effects of chronic resveratrol treatment on vascular responsiveness of streptozotocin-induced diabetic rats. Biol Pharm Bull 2008;31(5):897-902.
30. Carnovale CE, Marinelli RA, Rodriguez Garay EA. Bile flow decrease and altered bile composition in streptozotocin-treated rats. Biochem Pharmacol 1986;35:2625-2628.
31. Carnovale CE, Rodriguez Garay EA. Reversible impairment of hepatobiliary function induced by streptozotocin in the rat. Experientia 1984;40: 248-250.
32. Srinivasan K, Viswanad B, Asrat L, Kaul CL, Ramarao P. Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: a model for type 2 diabetes and pharmacological screening. Pharmacol Res 2005;52:313-320.
33. Miatello R, Váquez M, Renna N, Cruzado M, Zumino AP, Risler N. Chronic administration of resveratrol prevents biochemical cardiovascular changes in fructose-fed rats. Am J Hypertens 2005;6:864-870.
34. Bujanda L, Hijona E, Larzabal M, Beraza M, Aldazabal P, Garcia-Urkia N, Sarasqueta C, Cosme A, Irastorza B, Gonzalez A, Arenas JI. Resveratrol inhibits nonalcoholic fatty liver disease in rats. BMC Gastroenterol 2008;8:40.
35. Bancroft J, Stevens A. Enzyme histochemistry: theory and practice of histological techniques. New York: Churchill Livingstone; 1996.
36. Reitman S, Frankel S. A colorimetric method for the determination of serum glutamic oxalacetic and glutamic pyruvic transaminases. Am J Clin Pathol 1957;28:56-63.
37. Yokode M, Hammer RE, Ishibashi S, Brown MS, Goldstein JL. Diet-induced hypercholesterolemia in mice: prevention by overexpression of LDL receptors. Science 1990;250:1273-1275.
38. Johnson D, Lardy H. Isolation of liver or kidney mitochondria. Methods Enzymol 1967;10:94.
39. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265-275.
40. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979;95:351-358.
41. Marklund S, Marklund G. Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur J Biochem 1974;47:469-474.
42. Sinha AK. Colorimetric assay of catalase. Anal Biochem 1972;47:389-394.
43. Moron MS, Depierre JW, Mannervik B. Levels of glutathione, glutathione reductase and glutathione S-transferase activities in rat lung and liver. Biochim Biophys Acta 1979;582:67-78.
44. Habig W, Pabst MJ, Jakoby W. Glutathione S-transferases. The first enzymatic step in mercapturic acid formation. J Biol Chem 1974;249:7130.
45. Benson AM, Hunkeler MJ, Talalay P. Increase of NADPH, quinone reductase activity by dietary antioxidant: possible role in protection against carcinogenesis and toxicity. Proc Natl Acad Sci U S A 1980;77:5216-5220.
46. Wolff SP, Jiang ZY, Hunt JV. Protein glycation and oxidative stress in diabetes mellitus and ageing. Free Radic Biol Med 1991;10:339-352.
47. King GL, Loeken MR. Hyperglycemia-induced oxidative stress in diabetic complications. Histochem Cell Biol 2004;122:333-338.
48. Wojtczak L, Schonfeld P. Effect of fatty acids on energy coupling processes in mitochondria. Biochim Biophys Acta, 1993;1183:41-57.
49. Olukman M, Sezer ED, Ulker S, Sömen EY, Cinar GM. Fenofibrate treatment enhances antioxidant status and attenuates endothelial dysfunction in streptozotocin-induced diabetic rats. Exp Diabetes Res 2010;2010:49-58.
50. Taskinen MR. Diabetic dyslipidemia. Atheroscler Suppl 2002;3:47-51.
51. Arvind K, Pradeepa R, Deepa R, Mohan V. Diabetes & coronary artery disease. Indian J Med Res 2002;116:163-176.
52. Sahreen S, Khan MR, Khan RA. Hepatoprotective effects of methanol extract of Carissa opaca leaves on CCl4-induced damage in rat. BMC Complement Altern Med 2011;11:48.
53. Su H, Hung L, Chen J. Resveratrol, a red wine antioxidant, possesses an insulin like effect in streptozotocin induced diabetic rats. Am J Physiol Endocr Metabol 2006;290:E1339-E1346.
54. Baur JA, Pearson KJ, Price NL, Jamieson HA, Lerin C, Kalra A, Prabhu VV, Allard JS, Lopez-Lluch G, Lewis K, Pistell PJ, Poosala S, Becker KG, Boss O, Gwinn D, Wang M, Ramaswamy S, Fishbein KW, Spencer RG, Lakatta EG, Le Couteur D, Shaw RJ, Navas P, Puigserver P, Ingram DK, de Cabo R, Sinclair DA. Resveratrol improves health and survival of mice on a high-calorie diet. Nature 2006;444:337-334.